E-Qure Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on E-Qure's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2021

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How E-Qure makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:EQUR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 210-100
30 Jun 210-100
31 Mar 210-100
31 Dec 200-100
30 Sep 200000
30 Jun 200000
31 Mar 200000
31 Dec 190000
30 Sep 190-100
30 Jun 190-220
31 Mar 190-220
31 Dec 180-220
30 Sep 180-220
30 Jun 180000
31 Mar 180-110
31 Dec 170-110
30 Sep 170-110
30 Jun 170-110
31 Mar 170-110
31 Dec 160-110
30 Sep 160-110
30 Jun 160-110
31 Mar 160-110
31 Dec 150-110
30 Sep 150-100
30 Jun 150-211
31 Mar 150-2501
31 Dec 140-2501
30 Sep 140-2610
30 Jun 140-2510
31 Mar 140-110
31 Dec 130-110
30 Sep 130000
30 Jun 130000
31 Mar 130000

Quality Earnings: Insufficient data to determine if EQUR has high quality earnings.

Growing Profit Margin: Insufficient data to determine if EQUR's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if EQUR's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare EQUR's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if EQUR's earnings growth over the past year exceeded the Medical Equipment industry average.


Return on Equity

High ROE: EQUR has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.